Schedule 13G ownership disclosure
Foghorn Therapeutics Inc
Security class unavailable · CUSIP: 344174107
Event date: 2024-09-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.3100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-24-001145
- Form type
- SC 13G
- Filer
- Flynn James E
- CIK
- CIK 1352546
- Filed
- Sep 20, 2024
- Reporting period
- Sep 13, 2024
- Description
- Schedule 13G beneficial ownership